Clinical Study

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer

Figure 4

Figure 3. QLQ-C30 symptom scale scores and financial problems.
862921.fig.004a
(a)
862921.fig.004b
(b)
862921.fig.004c
(c)
862921.fig.004d
(d)
862921.fig.004e
(e)
862921.fig.004f
(f)
862921.fig.004g
(g)
862921.fig.004h
(h)
862921.fig.004i
(i)